Home
About Us
Company Overview
Mission
Leadship
Milestones
Science
Technology Platforms
Research Areas
Pipeline
Partnerships
News
News
Contact Us
EN
中文
EN
Home
About Us
Science
Technology Platforms
Research Areas
Pipeline
Partnerships
News
News
Contact Us
News
News
News
11-30
2021
Sciwind Biosciences Acquires Global, Exclusive Rights to Develop and Commercialize Sanofi's GIP Receptor Agonists for the Treatment of Metabolic Disease
2021-11-30
10-12
2021
Sciwind Biosciences Completes $70 Million Series C Financing and Expands Leadership Team to Advance Metabolic Disease Pipeline
2021-10-12
07-11
2021
Sciwind Biosciences Appoints Dr. Weidong Zhong as Chief Strategy Officer and President of its US Subsidiary
2021-07-11
02-28
2021
Sciwind's Investigational New Drug Approved for NASH Trial
2021-02-28
02-18
2021
Sciwind Biosciences Secures US$37 Million Series B Financing
2021-02-18
<
1
2
3
4
5
>
